Clinical Utility of ImmunoCAP Tryptase

Last updated: 27th May, 2020

ImmunoCAP Tryptase is a well-known clinical marker in explaining severe reactions cause by insect venoms, drugs, or in systemic mastocytosis. High-baseline tryptase levels can indicate if a person may be predisposed to severe anaphylactic reactions; and precautionary measures, e.g., an epinephrine autoinjector and specific immunotherapy, may be considered.

 

Tryptase and Venoms

  • Tryptase can support the clinical assessment regarding need for therapy in patients being considered for venom-specific immunotherapy after previous reactions to bee and/or wasp stings
  • Tryptase can help guide VIT treatment and in deciding on lifelong treatment

Find out more about Tryptase and Venoms

View Flyer >

Typtase and Drug Reactions

  • Tryptase levels can assist in finding the cause of a severe reaction which can occur during surgery
  • Measurements of transiently elevated tryptase levels directly after the reaction can help to identify if the reaction was due to mast cell activation

Find out more about Tryptase and Drug Reactions

View Flyer >

Typtase and Mastocystosis

  • Tryptase baseline levels reflect the mast cell burden in the body
  • Together with clinical findings, ImmunoCAP Tryptase test results can help to rule in or rule out systemic mastocystosis
  • WHO (World Health Organization) minor diagnostic criterion for systemic mastocytosis includes a persistently elevated baseline serum tryptase value above 20 μg/l (1 μg/l = 1 ng/ml)

Find out more about Tryptase and Mastocytosis

View Flyer >

 

 

 

 

 

 

 

 

 

 

f


Find out more about the Clinical Utility of Tryptase

View Brochure >

Contact us for a quote

Contact Us Now >



Request a Quote

Request Quote

Go BackGo Back
Top